Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer’s disease neuropathology

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1750-1326

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer’s disease neuropathology ; volume:7 ; number:1 ; day:28 ; month:5 ; year:2012 ; pages:1-13 ; date:12.2012
Molecular neurodegeneration ; 7, Heft 1 (28.5.2012), 1-13, 12.2012

Creator: Bjorklund, Nicole L.

Contributor: Reese, Lindsay C.
Sadagoparamanujam, V-M
Ghirardi, Valeria
Woltjer, Randall L.
Taglialatela, Giulio
SpringerLink (Online service)

DOI: 10.1186/1750-1326-7-23

URN: urn:nbn:de:1111-2016073069529

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:53 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Bjorklund, Nicole L.
Reese, Lindsay C.
Sadagoparamanujam, V-M
Ghirardi, Valeria
Woltjer, Randall L.
Taglialatela, Giulio
SpringerLink (Online service)

Other Objects (12)

Neuropathology of the Alzheimer's continuum: an update

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway

Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer’s disease

Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change

Alzheimer disease models and human neuropathology: similarities and differences

Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

Neuropathology of the Alzheimer's continuum: an update

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway

Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer’s disease

Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change

Alzheimer disease models and human neuropathology: similarities and differences

Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

Neuropathology of the Alzheimer's continuum: an update

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway

Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer’s disease

Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change

Alzheimer disease models and human neuropathology: similarities and differences

Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer’s disease neuropathology

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Neuropathology of the Alzheimer's continuum: an update

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway

Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer’s disease

Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change

Alzheimer disease models and human neuropathology: similarities and differences

Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

Neuropathology of the Alzheimer's continuum: an update

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway

Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer’s disease

Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change

Alzheimer disease models and human neuropathology: similarities and differences

Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

Neuropathology of the Alzheimer's continuum: an update

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway

Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer’s disease

Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change

Alzheimer disease models and human neuropathology: similarities and differences

Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

Related objects

Reset password